Vaxcyte Inc (NASDAQ: PCVX) on Friday, soared 3.07% from the previous trading day, before settling in for the closing price of $30.90. Within the past 52 weeks, PCVX’s price has moved between $27.66 and $121.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -24.44%. With a float of $125.07 million, this company’s outstanding shares have now reached $128.94 million.
Let’s look at the performance matrix of the company that is accounted for 414 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Vaxcyte Inc (PCVX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Vaxcyte Inc is 2.92%, while institutional ownership is 113.81%. The most recent insider transaction that took place on Mar 05 ’25, was worth 353,699. In this transaction SVP, GEN COUNSEL & CORP SEC of this company sold 5,000 shares at a rate of $70.74, taking the stock ownership to the 41,620 shares. Before that another transaction happened on Mar 05 ’25, when Company’s Officer proposed sale 5,000 for $68.87, making the entire transaction worth $344,350.
Vaxcyte Inc (PCVX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -24.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -7.11% during the next five years compared to -29.88% drop over the previous five years of trading.
Vaxcyte Inc (NASDAQ: PCVX) Trading Performance Indicators
Vaxcyte Inc (PCVX) is currently performing well based on its current performance indicators. A quick ratio of 17.70 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.07, a number that is poised to hit -1.17 in the next quarter and is forecasted to reach -4.49 in one year’s time.
Technical Analysis of Vaxcyte Inc (PCVX)
Vaxcyte Inc (NASDAQ: PCVX) saw its 5-day average volume 2.11 million, a positive change from its year-to-date volume of 1.92 million. As of the previous 9 days, the stock’s Stochastic %D was 36.51%. Additionally, its Average True Range was 2.88.
During the past 100 days, Vaxcyte Inc’s (PCVX) raw stochastic average was set at 6.34%, which indicates a significant decrease from 43.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 88.68% in the past 14 days, which was lower than the 117.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $44.92, while its 200-day Moving Average is $81.31. Nevertheless, the first resistance level for the watch stands at $32.70 in the near term. At $33.56, the stock is likely to face the second major resistance level. The third major resistance level sits at $34.58. If the price goes on to break the first support level at $30.82, it is likely to go to the next support level at $29.80. The third support level lies at $28.94 if the price breaches the second support level.
Vaxcyte Inc (NASDAQ: PCVX) Key Stats
Market capitalization of the company is 4.11 billion based on 129,004K outstanding shares. Right now, sales total 0 K and income totals -463,930 K. The company made 0 K in profit during its latest quarter, and -140,720 K in sales during its previous quarter.
